Blue Chips End Down, Merck Recall Weighs
95023
The U.S. Dow Jones Industrial average  declined on Thursday after drug maker Merck & Co.MRK.N  recalled its widely sold Vioxx painkiller and its stock sunk 27  percent.
209328
Merck & Co. MRK.N on Thursday said  its third-quarter profit fell, hurt by negative effects of the  recall last month of its Vioxx arthritis drug.
560665
U.S. blue chips ended lower on Monday  as a disappointing sales forecast from Wal-Mart Stores Inc.  WMT.N cast a pall over sentiment, overshadowing a two-session  pullback in oil prices.
617970
Merck &amp; Co.&#39;s shares (MRK) fell 9.7 percent to the lowest price in almost nine years after the Wall Street Journal said yesterday the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
336343
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as charges for its Vioxx litigation settlement dragged down results and share prices.
431523
Blue-chips ended the day down, albeit off lows, as Northern Rock plummeted following its profit warning and news it is to tap the Bank of England (BoE) for emergency funding, while Wall Street turned down after weak retail sales data.
231347
Blue chips closed lower Friday after a volatile last hour of trade, as rumours of financial troubles among hedge funds unnerved the market, causing a reversal of earlier solid gains, with Wall Street holding up but coming off highs.
502435
US BLUE-CHIP stocks slid lower yesterday, pulled down by industrial bellwether Caterpillar, but technology shares remained higher after EBay posted strong earnings.
204838
U.S. stocks looked to open lower on  Thursday after drug company Merck & Co.MRK.N said it was  withdrawing a key drug, sending Dow Jones industrial futures  tumbling and dragging the broader market down as well.
540694
The blue-chip Dow Jones average fell  on Thursday after drug maker Merck & Co.MRK.N withdrew its  widely used Vioxx painkiller after evidence showed the drug  could increase risk of heart attack and stroke.
113768
Blue-chip stocks ended flat on Wednesday after trimming steep losses late in the session amid speculation the Federal Reserve may act to cut the discount rate. The Nasdaq and S&P 500 ended lower but well off their worst levels of the day.
682599
Blue chips closed lower, with the banking reporting season off to a bad start as mid-cap Bradford & Bingley's shares lost 23 percent after its results, and the Bank of England's hawkish inflation report having a more widespread negative effect, though Wall Street was higher.
704632
NEW YORK, Sept. 30 -- Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck said it would be forced to remove its best-selling Vioxx arthritis drug from the market. Merck's unexpected bad news left blue chips with a loss for the day, while high-tech stocks got a lift from bargain hunters.
282357
UK blue chips closed lower Thursday having spent much of the afternoon tracking Wall Street which was unsettled by rising oil prices and mixed economic data, but overall were subdued amid ongoing interest rate concerns at home.
63892
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove one of its best-selling arthritis drugs from the market due to serious health risks...
645040
U.S. blue-chips ended slightly lower  on Wednesday after Honeywell International Inc. HON.N and  J.P. Morgan Chase & Co. JPM.N disappointed investors with  quarterly reports, and high oil prices rekindled worries about  the impact on corporate profit margins.
737271
Blue chips closed lower after Wall Street fell back in reaction to stronger crude prices.